Investigating Spectral Selectivity of the bSSFP Sequence for High Resolution 3D Dynamic Hyperpolarized 13C MRI at 3T Using C2-Pyruvate and Urea
Eugene Milshteyn1, Cornelius von Morze1, Hong Shang1, Galen D Reed2, and Daniel B Vigneron1

1Radiology and Biomedical Imaging, UCSF, San Francisco, CA, United States, 2HeartVista, Menlo Park, CA, United States

Synopsis

Hyperpolarized 13C MR imaging can provide simultaneous assessments of metabolism and perfusion to study disease processes. High resolution dynamic imaging is needed to fully understand these processes, but is challenging, especially on clinically relevant systems. This project investigated new methods for spectral selectivity with SNR-efficient bSSFP sequences to provide improved high resolution 3D dynamic in vivo HP 13C MR imaging at 3T.

Purpose

Recent advances in hyperpolarization (HP) 13C methods have allowed exceptional characterization of metabolism and perfusion changes, specifically with HP pyruvate and urea MRI, respectively, that underlie various diseases processes1,2. The ability to obtain both sets of information and/or resolve multiple compounds in one scan via copolarization has been demonstrated in vivo in prior hyperpolarized 13C studies3. Several different k-space acquisitions have been utilized to achieve this spectral selectivity, including echo-planar spectroscopic imaging and echo-planar imaging4,5, although these acquisitions typically have lower spatial resolution. The bSSFP sequence offers the highest SNR per unit time, and consequently highest spatial resolution, but exhibits off-resonance effects that make spectral selectivity relatively more difficult6. While different methods for spectral selectivity have been successfully applied to the bSSFP sequence, particularly at high field7,8, adapting the sequence for high resolution 3D dynamic acquisitions at the clinically relevant field strength of 3T is more challenging. In this project we aimed to investigate two different methods for spectrally selective high resolution 3D dynamic bSSFP of copolarized [2-13C]pyruvate and [13C,15N2]urea at 3T.

Methods

Two different methods for spectrally selective bSSFP tested on a 3T GE MR scanner were (referred to by number from here on): (1) frequency encoding of both species simultaneously using a low gradient with wide readout bandwidth (“multiband” encoding)9; (2) individual acquisition of each species applying spectrally selective RF pulses with TR chosen to place the compound of interest in the passband and the other in the stopband. Figure 1 depicts each method as it would be used to acquire images of copolarized [2-13C]pyruvate and [13C,15N2]urea. 13C thermal phantom tests were performed with a custom 3D bSSFP sequence (single timepoint) to display efficacy of each of the methods. Two spherical phantoms, one filled with bicarbonate and one filled with acetate, were imaged. Method 1 aimed to separate the two phantoms by low bandwidth frequency encoding, while method 2 aimed to alternately excite and suppress an individual spectral line (i.e. bicarbonate signal) when on-resonance and off-resonance, respectively. In vivo experiments were initially performed on one Sprague-Dawley rat with copolarized [2-13C]pyruvate and [13C,15N2]urea, which have a frequency difference of 1412 Hz at 3T. Both methods were acquired with a flip angle of 50°, after a 25° preparatory pulse (no slice select gradients), 2.5 mm isotopic resolution, 6 s temporal resolution for each compound, 10 dynamic timepoints for a total scan time of 60 s, and the scans were started at 15 s after beginning of injection. The different experimental parameters were as follows: (1) 48 x 24 x 8 matrix size, 1.6 ms pulse with a TBW of 4, TR of 21.9 ms, and rBW of 2.824 kHZ; (2) 24 x 24 x 8 matrix size, 2 ms pulse with a TBW of 2, TR of 7 ms, and rBW of 15.625 kHZ. Both phantom and in vivo experiments were acquired using partial Fourier acquisition, with only ¾ of the phase encodes acquired. A projection onto convex sets (POCS) reconstruction was employed to reconstruct the raw data, and further reconstruction for the multiband data was performed as described previously9. In vivo DNP experiments used a HyperSense polarizer, and 3mL of copolarized 80 mM [2-13C]pyruvate/80 mM [13C,15N2]urea was injected via a tail vein catheter.

Results and Discussion

The phantom experiments successfully showed the capability of using both methods at 3T. Figure 2 shows the representative slice 13C images for both methods. Method 1 successfully features bicarbonate and acetate in two separate bands, and both spherical phantoms are in their correct location in the recombined image. Method 2 successfully demonstrated that choosing the appropriate TR results in the bicarbonate signal being located in the stopband and consequently the spherical phantom disappearing. Figure 3 shows the 3D urea images next to a representative 1H image of the rat for both methods for the first dynamic timepoint. Figures 4 and 5 show all 10 dynamic timepoints for both methods for urea and pyruvate, respectively. Method 2 appeared to have better SNR and longer lasting dynamics.

Conclusion

The ability to acquire spectrally selective high resolution 3D dynamic images at 3T via the bSSFP sequence is demonstrated here using two separate methods, multiband encoding and spectrally selective RF pulses with an appropriate TR. Individual images of [2-13C]pyruvate and [13C,15N2]urea were successfully acquired within one scan. These methods can be potentially applied to other systems that require imaging of multiple resonances, such as pH measurement with HP [13C]bicarbonate. With further optimization of each method, higher resolution can be achieved and applied to various disease processes, and ultimately translated to clinical imaging.

Acknowledgements

The authors would like to thank Dr. Jeremy Gordon, Mark Van Criekinge, Lucas Carvajal, Hsin-yu Chen, and Zihan Zhu for all their help and funding from the NIH (P41EB013598).

References

1. Kurhanewicz, J. et al. Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia 13, 81–97 (2011).

2. Von Morze, C. et al. Investigating tumor perfusion and metabolism using multiple hyperpolarized 13C compounds: HP001, pyruvate and urea. Magn. Reson. Imaging 30, 305–311 (2012).

3. Von Morze, C. et al. Simultaneous Multiagent Hyperpolarized 13C Perfusion Imaging. Magn. Reson. Med. 72, 1599–1606 (2014).

4. Larson, P. E. Z. et al. Fast Dynamic 3D MRSI with Compressed Sensing and Multiband Excitation Pulses for Hyperpolarized 13C Studies. Magn. Reson. Med. 65, 610–619 (2011).

5. Gordon, J. W., Machingal, S., Kurhanewicz, J., Vigneron, D. & Larson, P. Ramp-Sampled, Symmetric EPI for Rapid Dynamic Metabolic Imaging of Hyperpolarized 13C Substrates on a Clinical MRI Scanner. in Proceedings of the International Society for Magnetic Resonance in Medicine 23 (2015) 4605.

6. Scheffler, K. & Lehnhardt, S. Principles and applications of balanced SSFP techniques. Eur. Radiol. 13, 2409–2418 (2003).

7. Von Morze, C. et al. Frequency-specific SSFP for hyperpolarized 13C metabolic imaging at 14.1 T. Magn. Reson. Imaging 31, 163–170 (2013).

8. Varma, G. et al. Selective spectroscopic imaging of hyperpolarized pyruvate and its metabolites using a single-echo variable phase advance method in balanced SSFP. Magn. Reson. Med. 00, n/a–n/a (2015).

9. Von Morze, C. et al. Multi-band frequency encoding method for metabolic imaging with hyperpolarized [1-(13)C]pyruvate. J. Magn. Reson. 211, 109–13 (2011).

Figures

Figure 1: Depiction of each method as related to acquisition of [2-13C]pyruvate and [13C,15N2]urea. Method 1 is multiband encoding, whereby each compound is separated into different frequency bands for spatial encoding after the readout bandwidth is made larger than conventional imaging. Method 2 shows each compound placed into a passband or stopband based on the TR and center frequency chosen, with the center frequency alternating to acquire both compounds.

Figure 2: 13C phantom depiction of each method. Method 1, located on top, shows bicarbonate and acetate being placed into separate frequency bands (top left), with the recombined image (top right) depicting each compound in one FOV in their proper locations. Method 2, located on the bottom, shows the appearance (bottom left) and disappearance (bottom right) of bicarbonate depending on the condition of on- or off-resonance.

Figure 3: Full 3D view of the first timepoint for [13C,15N2]urea for both methods next to a 1H image of the rat corresponding to slice 5, outlined in black. Both methods had similar SNR in the first time point, and distribution of urea in kidneys and aorta is clearly visible.

Figure 4: Depiction of all 10 dynamic timepoints for [13C,15N2]urea of slice 5 for both methods. After the first timepoint, method 2 appeared to have higher SNR at all subsequent timepoints, although both methods had enough SNR to visualize distribution in kidneys and aorta for multiple timepoints.

Figure 5: Depiction of all 10 dynamic timepoints for [2-13C]pyruvate of slice 5 for both methods. The [2-13C]pyruvate decays quickly away after the first timepoint, although signal can still be seen in the aorta in subsequent timepoints.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
2349